Robert Desantis Sells 376 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) EVP Robert Desantis sold 376 shares of the stock in a transaction on Monday, April 29th. The stock was sold at an average price of $375.39, for a total value of $141,146.64. Following the transaction, the executive vice president now owns 5,507 shares of the company’s stock, valued at approximately $2,067,272.73. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website.

Robert Desantis also recently made the following trade(s):

• On Friday, April 26th, Robert Desantis sold 1,498 shares of Intuitive Surgical stock. The stock was sold at an average price of $369.92, for a total value of $554,140.16.
• On Monday, March 11th, Robert Desantis sold 329 shares of Intuitive Surgical stock. The stock was sold at an average price of $390.16, for a total value of $128,362.64.
• On Friday, March 8th, Robert Desantis sold 20,296 shares of Intuitive Surgical stock. The stock was sold at an average price of $393.80, for a total value of $7,992,564.80.

Intuitive Surgical Stock Performance

Shares of ISRG stock opened at $371.70 on Thursday. Intuitive Surgical, Inc. has a fifty-two week low of $254.85 and a fifty-two week high of $403.76. The company has a market capitalization of $131.84 billion, a P/E ratio of 67.09, a PEG ratio of 4.83 and a beta of 1.36. The stock has a 50 day moving average price of $385.79 and a two-hundred day moving average price of $348.35.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Thursday, April 18th. The medical equipment provider reported $1.50 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.40 by $0.10. Intuitive Surgical had a return on equity of 12.91% and a net margin of 27.16%. The firm had revenue of $1.89 billion for the quarter, compared to analysts’ expectations of $1.87 billion. During the same period in the previous year, the firm earned $1.00 earnings per share. The business’s revenue was up 11.5% compared to the same quarter last year. As a group, equities analysts predict that Intuitive Surgical, Inc. will post 4.8 earnings per share for the current year.

Institutional Investors Weigh In On Intuitive Surgical

Several hedge funds and other institutional investors have recently added to or reduced their stakes in ISRG. Brookstone Capital Management grew its stake in Intuitive Surgical by 277.7% in the third quarter. Brookstone Capital Management now owns 7,259 shares of the medical equipment provider’s stock worth $1,985,000 after purchasing an additional 5,337 shares during the period. Commonwealth Equity Services LLC grew its stake in Intuitive Surgical by 10.9% in the third quarter. Commonwealth Equity Services LLC now owns 61,148 shares of the medical equipment provider’s stock worth $17,873,000 after purchasing an additional 6,018 shares during the period. RMR Wealth Builders grew its stake in Intuitive Surgical by 66.5% in the third quarter. RMR Wealth Builders now owns 4,076 shares of the medical equipment provider’s stock worth $1,191,000 after purchasing an additional 1,628 shares during the period. Accurate Wealth Management LLC grew its stake in Intuitive Surgical by 4.1% in the third quarter. Accurate Wealth Management LLC now owns 5,094 shares of the medical equipment provider’s stock worth $1,403,000 after purchasing an additional 199 shares during the period. Finally, Balboa Wealth Partners grew its stake in Intuitive Surgical by 3.3% in the third quarter. Balboa Wealth Partners now owns 5,619 shares of the medical equipment provider’s stock worth $1,642,000 after purchasing an additional 180 shares during the period. 83.64% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several research analysts have commented on ISRG shares. StockNews.com downgraded Intuitive Surgical from a “buy” rating to a “hold” rating in a research note on Thursday, February 29th. Wells Fargo & Company raised their target price on Intuitive Surgical from $363.00 to $416.00 and gave the stock an “overweight” rating in a research note on Friday, January 19th. BTIG Research raised their price target on Intuitive Surgical from $412.00 to $421.00 and gave the company a “buy” rating in a report on Friday, April 19th. Stifel Nicolaus raised their price target on Intuitive Surgical from $420.00 to $430.00 and gave the company a “buy” rating in a report on Monday, April 8th. Finally, Citigroup raised their price target on Intuitive Surgical from $428.00 to $462.00 and gave the company a “buy” rating in a report on Wednesday, April 3rd. Five analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $396.17.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.